IOMERON 300

国家: 以色列

语言: 英文

来源: Ministry of Health

现在购买

资料单张 资料单张 (PIL)
25-07-2022
产品特点 产品特点 (SPC)
06-11-2023
公众评估报告 公众评估报告 (PAR)
07-09-2023

有效成分:

IOMEPROL

可用日期:

DEXCEL LTD, ISRAEL

ATC代码:

V08AB10

药物剂型:

SOLUTION FOR INJECTION

组成:

IOMEPROL 612.4 MG/ML

给药途径:

I.V, INTRA-ARTERIAL

处方类型:

Required

厂商:

BRACCO IMAGING S.P.A., ITALY

治疗组:

IOMEPROL

治疗领域:

IOMEPROL

疗效迹象:

Contrast medium for diagnostic radiology. Intravenous urography ( in adults and paediatrics), peripheral phlebography, CT (brain and body), cavernosography, intravenous DSA, conventional angiography, intraarterial DSA, angiocardiography (in adults and paediatrics), conventional selective coronary arteriography, interventional coronary arteriography, ERCP, arthrography, hysterosalpingography, fistulography, discography, galactography, chloangiography, dacryocystography, sialography, retrograde urethrography, retrograde pyelo-ureterography.

授权日期:

2021-12-31

资料单张

                                _ _
ינוי
2022
IOMERON 300, 350, 400 MG, SOLUTION FOR INJECTION
,דבכנ יאופר תווצ
תרבח
מ"עב לסקד
ןוכדע לע םכעידוהל תשקבמ
ןולעב
אפורל
רישכתה לש
םי
:
א
ןורמוי
300
,
350
,
400
.
העדוהב
וז
םינוכדעה םיטרופמ
דבלב יתוחיטבה עדימב הרמחה םיווהמה
.
ןייעל שי ,אלמ עדימל
ןולעב
.
אפורל ןולעה
ופורתה רגאמב םוסרפל חלשנ
לבקל ןתינו תואירבה דרשמ רתאבש ת
ו
ספדומ
לעבל היינפ י"ע
:םושירה
לסקד
מ"עב
לסקד 'חר ,
1
אביקע רוא ,
3060000
:'לט ,לארשי ,
04-6364000
. בכרה
:רישכתה
.
respectively
iomeprol 61.24 g, 71.44 g, 81.65 g
Each 100 ml of solution contains
יוותה
תו
רשואמ
ו
:ת
Contrast medium for diagnostic radiology.
IOMERON 300: Intravenous urography (in adults and paediatrics),
peripheral phlebography,
CT (brain and body), cavernosography, intravenous DSA, conventional
angiography,
intraarterial DSA, angiocardiography (in adults and paediatrics),
conventional selective
coronary arteriography, interventional coronary arteriography, ERCP,
arthrography,
hysterosalpingography, fistulography, discography, galactography,
chloangiography,
dacryocystography, sialography, retrograde urethrography, retrograde
pyelo-ureterography.
IOMERON 350:
Intravenous urography (in adults and paediatrics), CT (body),
intravenous
DSA, conventional angiography, intraarterial DSA, angiocardiography
(in adults and
paediatrics), conventional selective coronary arteriography,
interventional coronary
arteriography, arthrography, hysterosalpingography, fistulography,
galactography,
retrograde cholangiography, dacryocystography, sialography.
IOMERON 400: Intravenous urography (in adults including those with
renal impairment or
diabetes), CT (body), conventional angiography, intraarterial DSA,
angiocardiography (in
adults and paediatrics), conventional selective coronary
arteriography, interventional
co
                                
                                阅读完整的文件
                                
                            

产品特点

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
IOMERON
® 300
IOMERON
® 350
IOMERON
® 400
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
IOMERON
®
300
100 ml of solution contains:
Active ingredient: Iomeprol: 61.24 g
IOMERON
®
350
100 ml of solution contains:
Active ingredient: Iomeprol: 71.44 g
IOMERON
®
400
100 ml of solution contains:
Active ingredient: Iomeprol: 81.65 g
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
IOMEPROL,
N,
N’
-bis(2,
3-dihydroxypropyl)-5[(hydroxyacetyl)methylamino]-2,
4,
6-triiodo-1,
3-
benzenedicarboxamide, the active component of lomeron
®
, is a triiodinated, non-ionic, water soluble,
nephrotropic, low-osmolality X-ray contrast medium with a molecular
weight of 777.09, formulations of which
yield contrast media of particularly low osmolality and viscosity in
comparison with other non-ionic media.
lomeprol has been formulated in a wide range of concentrations (up to
400 mg iodine/ml). All have proved to
be extremely stable both to heat sterilization and prolonged room
temperature storage, without the chelator
(EDTA salt) required by other contrast agents.
Solution for injection displaying the following physico-chemical
characteristics by Iodine strengths as
below:
_Iodine _
_concentration _
_mgI/mL _
_Osmolality _
_mOsmol/kg water _
_(x _

_ s_

_t95)* _
_Viscosity _
_mPa_

_s _
_(x _

_ s_

_t95)* _
_ _
_37° C _
_20°C _
_37° C _
300
521

24
8.1

0.7
4.5

0.4
350
618

29
14.5

1.1
7.5

0.6
400
726

34
27.5

2.3
12.6

1.1
*Steam pressure method
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Contrast medium for diagnostic radiology.
IOMERON 300
Intravenous urography (in adults and paediatrics), peripheral
phlebography, CT (brain and
body), cavernosography, intravenous DSA, conventional angiography,
intraarterial DSA,
angiocardiography (in adults and paediatrics), conventional selective
coronary
arteriography, interventional coronary arteriography, ERCP,
arthrography,
hysterosalpingograph
                                
                                阅读完整的文件
                                
                            

搜索与此产品相关的警报

查看文件历史